Evaluating the Immunoreactivity of Ailanthus Altissima (The Tree of Heaven) Pollen Extract in Atopic Patients.


Journal

Iranian journal of allergy, asthma, and immunology
ISSN: 1735-5249
Titre abrégé: Iran J Allergy Asthma Immunol
Pays: Iran
ID NLM: 101146178

Informations de publication

Date de publication:
16 Apr 2020
Historique:
received: 12 08 2019
accepted: 15 09 2019
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 10 2 2021
Statut: epublish

Résumé

IgE-mediated hypersensitivity reaction to pollens is a common health problem in atopic patients. In this regard, the assessment of the allergenicity of highly pollinating plants would be demanding. Based on the increment of Ailanthus altissima (A. altissima) tree in some parts of Iran and considering its probable role in respiratory allergy, in this study, we aimed to investigate its IgE-immunoreactivity and in diagnostic applications. One hundred and twenty-five allergic rhinitis patients who were diagnosed as high IgE responders and demonstrated seasonal rhinitis or rhinoconjunctivitis, as well as 20 healthy controls (HCs) with no allergic symptoms, were enrolled in this study. Total protein extract was prepared from A. altissima pollens and subjected to quality control experiments and finally used in ELISA and western blotting studies. Approximately 24% of the atopic patients (30 from 125) showed positive immunoreactivity to A. altissima extract. The median (IQR) of absorbance (450 nm) of the specific IgE against A. altissima pollen extract in HCs and positive groups were 0.33 (0.28-0.42) and 0.59 (0.36-0.79), respectively (p<0.001). Receiver operating characteristics (ROC) curve analysis of the specific ELISA results, revealed a cut-off value of 0.46 and a sensitivity of 70% and specificity of 100%. Western blotting with the sera positive cases revealed that the main immunoreactive proteins range from 10 to 70 kDa. This study revealed that some of A. altissima pollen proteins ranging from 10 to 70 kDa show IgE-reactivity in atopic patients and may play a role in their allergic reaction symptoms.

Identifiants

pubmed: 32372626
doi: 10.18502/ijaai.v19i2.2763
doi:

Substances chimiques

Allergens 0
Antigens, Plant 0
Plant Extracts 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132-138

Auteurs

Azam Samei (A)

Department of Immunology, Iran University of Medical Sciences, Tehran, Iran AND Department of Laboratory Sciences, Kashan University of Medical Sciences, Kashan, Iran. azsamei@gmail.com.

Morteza Fallahpour (M)

Department of Allergy and Clinical Immunology, Rasul e Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. fallahpour.morteza@gmail.com.

Mohammad Reza Bolouri (MR)

Department of Immunology, Iran University of Medical Sciences, Tehran, Iran. bolouri.mr@gmail.com.

Ahmad-Reza Mahmoudi (AR)

Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran. azsamei@gmail.com.

Farzad Nasri (F)

Department of Immunology, Iran University of Medical Sciences, Tehran, Iran. farzadnasri888@yahoo.com.

Farhad Seif (F)

Department of Immunology and Allergy, Academic Center for Education, Culture and Research, Tehran, Iran. farhad.seif@outlook.com.

Majid Khoshmirsafa (M)

Department of Immunology, Iran University of Medical Sciences, Tehran, Iran. mj.khoshmirsafa@hotmail.com.

Hossien Batooli (H)

Kashan Botanical Garden, Research Institute of Forests and Rangelands, Agricultural Research, Education and Extension Organization (AREEO), Tehran, Iran. azsamei@gmail.com.

Mehdi Shekarabi (M)

Department of Immunology, Iran University of Medical Sciences, Tehran, Iran AND Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran. shekarabi_m@yahoo.com.

Reza Falak (R)

Department of Immunology, Iran University of Medical Sciences, Tehran, Iran AND Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran. falak.r@iums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH